Kelly Evans @KellyCNBC · 19 Aug 2026
I have to say, when Merck called me last night with the mRNA cancer vaccine news (embargoed, of course), I literally yelped in reaction. Consider this: Between this spring's Revolution Medicines success with a KRAS-targeted drug and now Merck and Moderna's success with an mRNA
420 406Views
4 239Likes
469Reposts
98Replies
54Quotes
0Bookmarks
Is that a lot?
24.9×vs this author's median16 848 views is typical
80Percentile for this authorof 10 recent posts
145×vs 10K–100K median2 896 views is typical
8.1× audienceReachviews ÷ followers
1.16%Engagement rateof viewers reacted